Artemisia Supreme by Supreme Nutrition Products

POSSIBLY EFFECTIVE

• Allergic rhinitis (hay fever). Sweet Annie sublingual immunotherapy drops seem to be beneficial for preventing or reducing seasonal allergic rhinitis and rhinoconjunctivits symptoms related to Sweet Annie (Artemisia annua) pollen. Details: A large clinical study in adults with Artemisia annua (Sweet Annie) pollen-induced seasonal allergic rhinitis shows that taking sublingual drops of a glycerinated allergen extract of Sweet Annie for 32 weeks, beginning 4 months prior to pollen season, improves combined symptom and rescue medication use scores by 22% when compared with placebo. However, in this study the beneficial effects of Sweet Annie appear to be limited to patients mono-sensitized to its pollen; there was no significant improvement in patients who were also sensitized to other pollens (106441). A smaller clinical study shows that taking these drops beginning as early as 8-9 weeks pre-pollen season modestly improves both symptom and rescue medication scores when compared to a control group receiving only symptomatic drugs. In this study, the beneficial effects occurred in patients mono-sensitized to Artemisia pollen, as well as those patients who were also sensitized to other pollens (109315). The validity of this study is limited by the lack of blinding and placebo-control. A small open-label clinical study in adults with confirmed sensitization to Artemisia annua (Sweet Annie) pollen and a history of seasonal allergic rhinoconjunctivitis shows that taking standardized Sweet Annie sublingual immunotherapy drops combined with pharmacotherapy for a year before allergy season improves rhinoconjunctivitis symptoms and rescue medication use during allergy season when compared with pharmacotherapy alone (112392). Two additional open-label studies also show that Sweet Annie sublingual immunotherapy, given for up to 16 months, improves rhinoconjunctivitis symptoms and rescue medication use for up to 2 allergy seasons when compared with control in individuals who are mono-sensitized to Sweet Annie and in those who are poly-sensitized to Sweet Annie plus a variety of other pollen allergens (112393,112394). All of the aforementioned studies were conducted in China where Sweet Annie is the primary outdoor pollen responsible for seasonal allergic rhinitis and rhinoconjunctivitis (106441,109315,112392,112393,112394). As a result, the applicability of the findings to other geographical regions may be limited.

INSUFFICIENT RELIABLE EVIDENCE to RATE

• Malaria. It is unclear if Sweet Annie is beneficial for malaria. Details: Some research shows that consuming Sweet Annie tea orally for 4-7 days might improve symptoms and decrease parasite load in patients with malaria (11055,11058). The Sweet Annie constituent artemisinin is of interest for its antimalarial activity, possibly by inactivating the parasite (3185,11056,11057,11059). Derivatives of the artemisinin constituent are occasionally used as medication in combination with other antimalarial compounds (103258). However, there is some concern that using Sweet Annie tea itself as monotherapy may lead to poor long-term outcomes, as well as resistance to artemisinin derivatives (11055,11059).
• Nonalcoholic fatty liver disease (NAFLD). It is unclear if Sweet Annie is beneficial for NAFLD. Details: A clinical study in adults with borderline and mild NAFLD shows that taking an aqueous extract of Sweet Annie 686 mg twice daily for 8 weeks reduces alanine aminotransferase (ALT) concentrations from baseline by a mean of 16 units/L, compared with a reduction of 7 units/L in the placebo group. Aspartate aminotransferase (AST) concentrations and fatigue scores were also improved in those receiving Sweet Annie (106442). However, there have also been reports of liver toxicity with Sweet Annie (16895,103254,103255).
• Osteoarthritis. It is unclear if Sweet Annie is beneficial for osteoarthritis. Details: One small clinical study shows that taking a specific Sweet Annie extract (Arthrem, Promissia Limited) 150 mg twice daily for 12 weeks reduces pain and stiffness and improves function when compared to baseline in patients with osteoarthritis of the hip or knee. However, taking this same extract at a dose of 300 mg twice daily did not produce the same effects (94521). In an extension of this study, the therapeutic effects of taking Sweet Annie 150 mg twice daily were maintained for 6 additional months (94520). However, the validity of these results is limited due to a lack of statistical comparison between the Sweet Annie and placebo groups.
• Rheumatoid arthritis (RA). It is unclear if Sweet Annie is beneficial for RA. Details: Preliminary clinical research in patients with RA shows that taking Sweet Annie 30 grams in warm water once daily for 48 weeks in combination with leflunomide and methotrexate modestly reduces pain, swelling, and tenderness in the joints and increases the cessation of corticosteroids when compared with leflunomide and methotrexate alone (109318). The validity of this study is limited by the lack of a placebo or adequate blinding. More evidence is needed to rate Sweet Annie for these uses.

(Read more about SWEET ANNIE)

POSSIBLY SAFE ...when used orally and appropriately, short-term. Sweet Annie 300 mg daily has been used with apparent safety in studies lasting up to 9 months (11055,94520,94521). Sweet Annie tea, prepared from dried leaves and twigs and consumed in divided doses daily, has been used with apparent safety for up to 7 days (11055,11058). While rare, there is some concern that Sweet Annie might cause liver damage (16895,103254,103255).

POSSIBLY SAFE ...when used sublingually and appropriately, short-term. Sweet Annie up to 2400 biological units daily as sublingual immunotherapy has been used with apparent safety in studies lasting up to 16 months (106441,112392,112393,112394). There is insufficient reliable information available about the safety of Sweet Annie when used topically.

PREGNANCY AND LACTATION:
Insufficient reliable information available; avoid using.

(Read more about SWEET ANNIE)

CYTOCHROME P450 2B6 (CYP2B6) SUBSTRATES Interaction Rating = Moderate Be cautious with this combination. Severity = Moderate •  Occurrence = Possible •  Level of Evidence = D Sweet Annie may alter plasma levels and clinical effects of drugs metabolized by CYP2B6.  Details In vitro research shows that the Sweet Annie constituent artemisinin induces CYP2B6, possibly increasing CYP2B6 activity by 1.6-fold (92501,109316). However, Sweet Annie extract seems to inhibit the activity of CYP2B6 in vitro, suggesting that other constituents of Sweet Annie play a role in its effects on the overall activity of this enzyme (109316). More information is needed to determine whether taking Sweet Annie extract affects the metabolism of CYP2B6 substrates.

CYTOCHROME P450 3A4 (CYP3A4) SUBSTRATES Interaction Rating = Moderate Be cautious with this combination. Severity = Moderate •  Occurrence = Possible •  Level of Evidence = D Sweet Annie may alter plasma levels and clinical effects of drugs metabolized by CYP3A4.  Details In vitro research shows that the Sweet Annie constituent artemisinin induces CYP3A4, possibly increasing CYP3A4 activity by 1.9-fold (92501). However, Sweet Annie extract seems to inhibit the activity of CYP3A4 in vitro, suggesting that other constituents of Sweet Annie play a role in its effects on the overall activity of this enzyme (109316). More information is needed to determine whether taking Sweet Annie extract affects the metabolism of CYP3A4 substrates.

HEPATOTOXIC DRUGS Interaction Rating = Moderate Be cautious with this combination. Severity = High •  Occurrence = Possible •  Level of Evidence = D Theoretically, concomitant use might have additive adverse hepatotoxic effects.  Details There is some concern that Sweet Annie can adversely affect the liver (16895,103254,103255).

(Read more about SWEET ANNIE)

General ...Orally, Sweet Annie is generally well-tolerated.
Most Common Adverse Effects:
Orally: Nausea and vomiting.
Serious Adverse Effects (Rare):
Orally: Hepatotoxicity.

Gastrointestinal ...Orally, Sweet Annie might cause gastrointestinal upset including nausea and vomiting in some patients (11058,112393).

Hepatic ...Orally, Sweet Annie might cause hepatic adverse effects (16895,103254,103255). In one case, a 52-year-old patient developed hepatitis after taking the Sweet Annie constituent artemisinin 200 mg three times daily for 10 days. The patient developed abdominal pain and dark urine and was found to have elevated liver enzymes consistent with hepatitis. Symptoms resolved within 2 weeks of discontinuing use. Although it is possible this supplement caused liver disease in this patient, it is not certain. In clinical trials evaluating artemisinin, elevated liver enzymes have only been reported in around 0.9% of patients. However, the dose of artemisinin in this case was substantially higher than a typical dose (16895). A case of severe acute cholestatic hepatitis has also been reported in a 51-year-old male who drank Sweet Annie tea daily, prepared using 1.25 grams of Sweet Annie powder, for malaria prophylaxis during a 4-week trip to Ethiopia. Three weeks after his return, he presented with malaise, abdominal discomfort, jaundice, elevated liver enzymes, and markers of cholestasis. The patient was treated with corticosteroids and ursodeoxycholic acid and ultimately recovered (103255).
A series of cases linking the use of a supercritical carbon dioxide extract of Sweet Annie to hepatoxicity has also been reported. Of the 29 reports of adverse hepatic reactions to this extract, 19 patients noted symptoms within 12 weeks of starting the extract, 16 patients experienced jaundice, and 9 patients required hospitalization. Other common symptoms of hepatotoxicity included abdominal pain, vomiting, nausea, fever, headache, anorexia, malaise, fatigue, and lethargy. All but one case involved doses below or up to the extract's recommended dose of 300 mg daily. Upon discontinuation, symptoms resolved completely or were improved in nearly all cases (103254).

Immunologic ...One case of a mild allergic reaction to Sweet Annie tea has been reported. The reaction was characterized by a rash and cough that resolved quickly and did not require treatment (11059). When low doses are taken sublingually by individuals allergic to Sweet Annie, numbness of the tongue and throat itching have been reported (109315,112392,112393,112394).

(Read more about SWEET ANNIE)